Keizo Sogabe

683 total citations
19 papers, 589 citations indexed

About

Keizo Sogabe is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Keizo Sogabe has authored 19 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Biochemistry. Recurrent topics in Keizo Sogabe's work include Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pelvic floor disorders treatments (2 papers). Keizo Sogabe is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pelvic floor disorders treatments (2 papers). Keizo Sogabe collaborates with scholars based in Japan and United States. Keizo Sogabe's co-authors include T Ono, Y. Notsu, Atsushi Nomoto, Stoppani Ao, Yoshitada Notsu, Takaharu Ono, Nancy F. Roeser, Joel M. Weinberg, S. Nakanishi and ATSUKO NODA and has published in prestigious journals such as Kidney International, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Keizo Sogabe

19 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keizo Sogabe Japan 11 363 199 192 55 54 19 589
Kenro Imaeda Japan 13 235 0.6× 174 0.9× 130 0.7× 29 0.5× 50 0.9× 37 591
Joshua Astern United States 10 276 0.8× 174 0.9× 154 0.8× 54 1.0× 33 0.6× 12 620
Abdulrahman K. Doughan United States 4 293 0.8× 392 2.0× 196 1.0× 31 0.6× 24 0.4× 5 820
Dale A. Kinzenbaw United States 16 251 0.7× 227 1.1× 227 1.2× 51 0.9× 45 0.8× 19 845
Ken Terata Japan 9 252 0.7× 198 1.0× 224 1.2× 27 0.5× 108 2.0× 17 607
Graham H. Allcock United Kingdom 13 496 1.4× 229 1.2× 278 1.4× 81 1.5× 37 0.7× 18 701
Mary Pat Kunert United States 15 210 0.6× 120 0.6× 183 1.0× 51 0.9× 11 0.2× 22 653
John R. Vane United Kingdom 12 670 1.8× 221 1.1× 274 1.4× 92 1.7× 98 1.8× 13 1.1k
Miki Asano Japan 18 267 0.7× 410 2.1× 301 1.6× 127 2.3× 164 3.0× 72 978
Naotaka Sekiguchi Japan 10 285 0.8× 250 1.3× 113 0.6× 22 0.4× 19 0.4× 22 803

Countries citing papers authored by Keizo Sogabe

Since Specialization
Citations

This map shows the geographic impact of Keizo Sogabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Sogabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Sogabe more than expected).

Fields of papers citing papers by Keizo Sogabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keizo Sogabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Sogabe. The network helps show where Keizo Sogabe may publish in the future.

Co-authorship network of co-authors of Keizo Sogabe

This figure shows the co-authorship network connecting the top 25 collaborators of Keizo Sogabe. A scholar is included among the top collaborators of Keizo Sogabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keizo Sogabe. Keizo Sogabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gotoh, Momokazu, Toshimitsu Kobayashi, & Keizo Sogabe. (2014). Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder. Neurourology and Urodynamics. 34(8). 730–735. 14 indexed citations
2.
Gotoh, Momokazu, Toshimitsu Kobayashi, & Keizo Sogabe. (2013). Impact of symptom improvement on patients' bother and quality of life in female patients with overactive bladder treated by solifenacin (SET‐Q). International Journal of Urology. 21(5). 505–511. 6 indexed citations
3.
Sogabe, Keizo, et al.. (2012). [Safety and efficacy of midazolam in children under mechanical ventilation in the intensive care unit].. PubMed. 61(11). 1245–60. 2 indexed citations
4.
Wakasugi, Masahiro, Keizo Sogabe, Toshimitsu Kobayashi, et al.. (2011). Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report. Journal of Infection and Chemotherapy. 17(5). 622–632. 17 indexed citations
5.
Tomita, Masayuki, et al.. (1997). Pharmacological profiles of FR161282, a new, nonpeptide vasopressin V2 receptor antagonist. The Japanese Journal of Pharmacology. 73. 136–136. 1 indexed citations
6.
Takiguchi, Yoshiharu & Keizo Sogabe. (1996). The selective endothelin ETA receptor antagonist FR139317 inhibits neointimal thickening in the rat. European Journal of Pharmacology. 309(1). 59–62. 7 indexed citations
7.
Sogabe, Keizo, et al.. (1996). Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney International. 50(3). 845–854. 51 indexed citations
8.
Sogabe, Keizo, et al.. (1993). Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 264(3). 1040–1046. 193 indexed citations
9.
Aramori, Ichiro, Keizo Sogabe, Hitoshi Kojo, et al.. (1993). Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.. Molecular Pharmacology. 43(2). 127–131. 81 indexed citations
10.
Sogabe, Keizo, et al.. (1993). An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sciences. 52(23). 1869–1874. 93 indexed citations
11.
Nagashima, Akira, et al.. (1993). The Pharmacological Characterization of FK 739, a New Angiotensin II-Receptor Antagonist. The Japanese Journal of Pharmacology. 63(3). 335–344. 9 indexed citations
12.
Sogabe, Keizo, et al.. (1992). A novel endothelin receptor antagonist: studies with FR139317. The Japanese Journal of Pharmacology. 58. 105–105. 15 indexed citations
13.
Takakura, Shoji, Keizo Sogabe, Hisashi Satoh, et al.. (1992). Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride. Neuroscience Letters. 141(2). 199–202. 28 indexed citations
14.
Miyata, Susumu, Michizane Hashimoto, Keizo Sogabe, et al.. (1992). WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. No. 89009. II. Biological characterization and pharmacological characterization of WS009 A and B.. The Journal of Antibiotics. 45(7). 1041–1046. 12 indexed citations
15.
Sogabe, Keizo, Hisakuni Hashimoto, & Mitsuyoshi Nakashima. (1985). Affinities of Adrenergic Drugs for α<sub>2</sub>-Adrenoceptors in Dog Saphenous Vein in Comparison with Those in Rat Brain or Human Platelets. Journal of Vascular Research. 22(3). 127–138. 4 indexed citations
16.
Nakashima, Mitsuyoshi, et al.. (1985). Anti-arrhythmic effect of nadolol in experimental arrhythmias: Comparison with propranolol and alprenolol.. Journal of Pharmacobio-Dynamics. 8(1). 1–10. 4 indexed citations
17.
NODA, ATSUKO, Kenji Matsuyama, Keizo Sogabe, et al.. (1979). Fate of hydralazine in man. I. Reactions under gastric conditions.. Chemical and Pharmaceutical Bulletin. 27(11). 2820–2826. 8 indexed citations
18.
NODA, ATSUKO, et al.. (1978). Quantitative determination of hydrazines berived from isoniazid in patients. I.. Journal of Pharmacobio-Dynamics. 1(2). 132–141. 32 indexed citations
19.
Iguchi, Sadao, Tsuyoshi Goromaru, ATSUKO NODA, Kenji Matsuyama, & Keizo Sogabe. (1977). Quantitative determination of hydrazines derived from isoniazid in man.. Chemical and Pharmaceutical Bulletin. 25(10). 2796–2800. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026